Mannatech (NASDAQ:MTEX) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEXFree Report) in a research report report published on Sunday morning. The firm issued a buy rating on the stock.

Mannatech Stock Performance

NASDAQ MTEX opened at $7.14 on Friday. The company has a quick ratio of 0.56, a current ratio of 1.08 and a debt-to-equity ratio of 0.09. Mannatech has a twelve month low of $6.75 and a twelve month high of $15.10. The stock has a 50-day moving average of $7.42 and a 200 day moving average of $8.20.

Mannatech (NASDAQ:MTEXGet Free Report) last announced its earnings results on Tuesday, May 14th. The company reported $0.63 earnings per share (EPS) for the quarter. Mannatech had a negative return on equity of 15.37% and a negative net margin of 1.31%. The firm had revenue of $29.39 million for the quarter.

About Mannatech

(Get Free Report)

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.

See Also

Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.